Document Detail


Vascular imaging in chronic kidney disease.
MedLine Citation:
PMID:  22531162     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: The chronic kidney disease (CKD) mineral bone disorder syndrome encompasses a number of metabolic, bone as well as vascular abnormalities of which vascular calcification is a prominent feature. Several noninvasive imaging techniques provide physicians with useful prognostic information beyond traditional cardiovascular and CKD-specific risk factors. We review the most recent evidence on vascular calcification screening as a tool for risk stratification in CKD patients.
RECENT FINDINGS: Cardiovascular aging is accelerated and is associated with a poor prognosis in CKD patients. Numerous traditional and nontraditional risk factors have been associated with this outcome. Imaging markers and serological risk factors do not carry the same prognostic information. In fact, whereas serum biomarkers reflect the risk to which the individual is exposed at the time of measurement, imaging markers represent the cumulative result of prolonged exposure to one or multiple risk factors. As such, they have often been demonstrated to be better outcome predictors than serological markers. In some cases, imaging markers have been suggested as desirable targets of therapy or to guide treatment individualization.
SUMMARY: Recent evidence suggests that cardiovascular imaging allows for cardiovascular risk stratification and treatment individualization in CKD patients.
Authors:
Antonio Bellasi; Paolo Raggi
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current opinion in nephrology and hypertension     Volume:  21     ISSN:  1473-6543     ISO Abbreviation:  Curr. Opin. Nephrol. Hypertens.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-01     Completed Date:  2012-10-03     Revised Date:  2013-05-02    
Medline Journal Info:
Nlm Unique ID:  9303753     Medline TA:  Curr Opin Nephrol Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  382-8     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Sant' Anna Hospital, Como, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arteries / metabolism,  pathology*,  physiopathology
Biological Markers / blood
Chronic Disease
Diagnostic Imaging* / methods
Disease Progression
Humans
Kidney Diseases / complications*,  therapy
Predictive Value of Tests
Prognosis
Risk Assessment
Risk Factors
Vascular Calcification / blood,  diagnosis*,  etiology,  physiopathology,  prevention & control
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bone disease in CKD.
Next Document:  Fibroblast growth factor 23 and the heart.